Andrea K. Biddle

Andrea K. Biddle

Auto-generated profile, based on publicly available information

Andrea K. Biddle

Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2014 in Journal of the American Heart Association
Verified
Journal Article
Open access
DKDio Kavalieratos
Dio Kavalieratos
EMEmma M. Mitchell
Emma M. Mitchell
TCTimothy S. Carey
Timothy S. Carey
SDSandesh Dev
Sandesh Dev
ABAndrea K. Biddle
Andrea K. Biddle
MWMorris Weinberger
Morris Weinberger
Background: Although similar to cancer patients regarding symptom burden and prognosis, patients with heart failure ( HF ) tend to receive palliative care far less frequently. We sought to explore factors perceived by cardiology, primary care, and palliative care providers to impede palliative care referral for HF patients. Methods and Results: We conducted semistructured interviews regarding (1) perceived needs of patients with advanced HF ; (2) knowledge, attitudes, and experiences with specialist palliative care; (3) perceived indications for and optimal timing of palliative care referral in HF ; and (4) perceived barriers to palliative care referral. Two investigators analyzed data using template analysis, a qualitative technique. We interviewed 18 physician, nurse practitioner, and physician assistant providers from 3 specialties: cardiology, primary care, and palliative care. Providers had limited knowledge regarding what palliative care is, and how it can complement traditional HF therapy to decrease HF ‐related suffering. Interviews identified several potential barriers: the unpredictable course of HF ; lack of clear referral triggers across the HF trajectory; and ambiguity regarding what differentiates standard HF therapy from palliative care. Nevertheless, providers expressed interest for integrating palliative care into traditional HF care, but were unsure of how to initiate collaboration. Conclusions: Palliative care referral for HF patients may be suboptimal due to limited provider knowledge and misperceptions of palliative care as a service reserved for those near death. These factors represent potentially modifiable targets for provider education, which may help to improve palliative care referral for HF patients with unresolved disease‐related burden.

1 February 1996 in Medical Care
Verified
Journal Article
Closed access
JLJeanne M. Lambrew
Jeanne M. Lambrew
GDGordon H. Defriese
Gordon H. Defriese
TCTimothy S. Carey
Timothy S. Carey
TRThomas C. Ricketts
Thomas C. Ricketts
ABAndrea K. Biddle
Andrea K. Biddle
The authors assessed the relationship between having a regular doctor and access to care, as measured by a set of preventive and primary care utilization indicators recommended by the Institute of Medicine. The 1987 National Medical Expenditure Survey was used in the analyses (n = 30,012). The results of the regression analyses suggest that individuals with any type of regular source of care had better access than those without a regular source of care. Persons with a regular doctor had better access to primary care than those with a regular site but no regular doctor. However, the apparent advantage of having a regular doctor over a regular site disappeared when only those individuals reporting a physician's office, clinic, or health maintenance organization as their regular source of care were compared. These results suggest that policies that promote the doctor-patient relationship will increase access, although the gains may be negligible for individuals who use mainstream primary care sites (physician's office, clinic, or health maintenance organization) versus sites such as walk-in clinics or emergency rooms.

18 May 1999 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
ARAllison B. Rosen
Allison B. Rosen
VFVance G. Fowler
Vance G. Fowler
GCG. Ralph Corey
G. Ralph Corey
SDStephen M. Downs
Stephen M. Downs
ABAndrea K. Biddle
Andrea K. Biddle
JJJames G. Jollis
James G. Jollis
The appropriate duration of therapy for catheter-associated Staphylococcus aureus bacteremia is controversial. Conventional practice dictates that all patients receive prolonged courses of intravenous antibiotics. Some clinicians recommend abbreviated therapeutic courses, but an alternate approach involves prospectively identifying patients for whom abbreviated therapy is appropriate. To determine the cost-effectiveness of transesophageal echocardiography (TEE) in establishing duration of therapy for catheter-associated S. aureus bacteremia. Cost-effectiveness analysis. MEDLINE search of literature; clinical data from patients with S. aureus bacteremia (n = 196) and patients with endocarditis (n = 60); and costs obtained from the study institution, regional home health agency, and national estimates of professional and technical fees. Patients with catheter-associated S. aureus bacteremia on native heart valves without intravenous drug use or clinically apparent metastatic infection, immunosuppression, or indwelling prosthetic devices. Patient lifetime. Societal. Antibiotic treatment based on TEE results compared with 2- or 4-week empirical therapy. Quality-adjusted life expectancy, costs, and incremental cost-effectiveness ratios. Compared with empirical short-course therapy, the TEE strategy cost $4938 per quality-adjusted life-year (QALY) gained. The effectiveness of the TEE strategy and the effectiveness of the long-course strategy were sufficiently similar that the additional cost of empirical long-course therapy ($1 667 971 per QALY) was higher than that which society usually considers cost-effective. In a four-way sensitivity analysis (endocarditis prevalence, TEE cost, short-course relapse rate, and TEE specificity), compared with empirical short-course therapy, the TEE strategy results ranged from cost savings to $155 624 per QALY. Within the limitations of existing empirical data, this study suggests that for patients with clinically uncomplicated catheter-associated S. aureus bacteremia, the use of TEE to determine therapy duration is a cost-effective alternative to 2- or 4-week empirical therapy.

1 October 2009 in Annals of Behavioral Medicine
Verified
Journal Article
Closed access
PDF file
MCMarci Kramish Campbell
Marci Kramish Campbell
CCCarol Carr
Carol Carr
BDBrenda DeVellis
Brenda DeVellis
BSBoyd Switzer
Boyd Switzer
ABAndrea Biddle
Andrea Biddle
RSRobert Sandler
Robert Sandler
Background. Healthful dietary patterns, including eating fruits and vegetables (F&V) and avoiding obesity, may decrease the risk of cancer and othe

1 May 2013 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
DBDaniel W. Belsky
Daniel W. Belsky
TMTerrie E. Moffitt
Terrie E. Moffitt
TBTimothy B. Baker
Timothy B. Baker
ABAndrea K. Biddle
Andrea K. Biddle
JEJames P. Evans
James P. Evans
ACAvshalom Caspi
Avshalom Caspi
Cigarette smoking is a costly, prevalent public health problem. The US Centers for Disease Control and Prevention attribute more than 400 000 deaths and $95 million in lost productivity to smoking during 2000-2004.1 Approximately 20% of adults still smoke daily despite widespread knowledge of smoking's health effects and increasing economic costs to smokers due to increasing taxes.2 Thus, more effective interventions to prevent smoking, motivate smoking cessation, and prevent relapse are needed.3-5

1 June 2012 in Archives of Pediatrics & Adolescent Medicine
Verified
Journal Article
Closed access
DBDaniel W. Belsky
Daniel W. Belsky
TMTerrie E. Moffitt
Terrie E. Moffitt
RHRenate Houts
Renate Houts
GBGary G. Bennett
Gary G. Bennett
ABAndrea K. Biddle
Andrea K. Biddle
ACAvshalom Caspi
Avshalom Caspi
To test how genomic loci identified in genome-wide association studies influence the development of obesity. A 38-year prospective longitudinal study of a representative birth cohort. The Dunedin Multidisciplinary Health and Development Study, Dunedin, New Zealand. One thousand thirty-seven male and female study members. We assessed genetic risk with a multilocus genetic risk score. The genetic risk score was composed of single-nucleotide polymorphisms identified in genome-wide association studies of obesity-related phenotypes. We assessed family history from parent body mass index data collected when study members were 11 years of age. Body mass index growth curves, developmental phenotypes of obesity, and adult obesity outcomes were defined from anthropometric assessments at birth and at 12 subsequent in-person interviews through 38 years of age. Individuals with higher genetic risk scores were more likely to be chronically obese in adulthood. Genetic risk first manifested as rapid growth during early childhood. Genetic risk was unrelated to birth weight. After birth, children at higher genetic risk gained weight more rapidly and reached adiposity rebound earlier and at a higher body mass index. In turn, these developmental phenotypes predicted adult obesity, mediating about half the genetic effect on adult obesity risk. Genetic associations with growth and obesity risk were independent of family history, indicating that the genetic risk score could provide novel information to clinicians. Genetic variation linked with obesity risk operates, in part, through accelerating growth in the early childhood years after birth. Etiological research and prevention strategies should target early childhood to address the obesity epidemic.